Clinical Trials
MCLA-158 (Petosemtamab) as single agent or in combination in advanced solid tumors
Disease Type: Colon , Disease Type: Solid Tumors
Phase 1/2 dose escalation and cohort expansion study evaluating MCLA-158 (Petosemtamab) as single agent or in combination in advanced solid tumors (MCLA-158-CL01)
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville